[Skip to Content]

Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians – (Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians, Published online: 2018-12-18; | doi:10.1038/s41433-018-0314-x)

Dec 18
2018

Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after female physicians, Published online: 18 December 2018; doi:10.1038/s41433-018-0314-x Response to: Comment on: Eponymous women in ophthalmology: syndromes with prominent eye manifestations named after

  • 18 December 2018

YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome – (YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome, Published online: 2018-12-18; | doi:10.1038/s41433-018-0308-8)

Dec 18
2018

YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome, Published online: 18 December 2018; doi:10.1038/s41433-018-0308-8 YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome

  • 18 December 2018

Ophthalmic Safety Alert – Do not use nitrous oxide when there is gas in an operated eye

Dec 18
2018

Intraocular air or gas is often used as a tamponade agent at the end of vitrectomy surgery to secure the retina. The two most common indications are retinal detachment and macular hole surgery. Intraocular gas is also being used increasingly in endothelial keratoplasties (lamellar corneal grafts) initially during the primary procedure or for “rebubbling” dislocated

  • 18 December 2018

1-year outcomes of the Xen45 glaucoma implant – (1-year outcomes of the Xen45 glaucoma implant, Published online: 2018-12-14; | doi:10.1038/s41433-018-0310-1)

Dec 14
2018

1-year outcomes of the Xen45 glaucoma implant 1-year outcomes of the Xen45 glaucoma implant, Published online: 14 December 2018; doi:10.1038/s41433-018-0310-1 1-year outcomes of the Xen45 glaucoma implant

  • 14 December 2018

Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis – (Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis, Published online: 2018-12-14; | doi:10.1038/s41433-018-0306-x)

Dec 14
2018

Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of Acanthamoeba keratitis Torn from the headlines: role of public awareness and bench- to-bedside research in prevention and treatment of <i>Acanthamoeba</i> keratitis, Published online: 14 December 2018; doi:10.1038/s41433-018-0306-x Torn from the headlines: role of public awareness and bench- to-bedside

  • 14 December 2018